CTI BioPharma Stock Price (NASDAQ:CTIC)

Add to My Stocks
$4.73 $0.01 (0.21%) CTIC stock closing price Feb 17, 2017 (Closing)
CTI BioPharma
17 FEB 2017
amigobulls logo
CTIC hand_up
CTIC vs S&P 500
Closing Price: Feb 17, 2017
$4.73 ( -0.21%)
S&P 500
2351.2 ( 0.17%)
52 Week Price Range
1 Year Return: -21.83%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

CTI BioPharma Snapshot Video

6 5 2

CTIC Stock Details

Prev Close* : $4.74
Market Cap:
Day Low: $4.66
52 Week Low: $3.07
Open: $4.7
Volume: 68066
Day High: $4.79
52 Week High: $7.60

Latest Stock Market News

Latest Articles

CTI BioPharma News - From Partners

CTIC Stockcharts

View CTIC PE ratio, PS ratio stocks charts and compare with peers.
CTIC Chart
Note: Compare CTI BioPharma stock price history with the index and industry peers.

CTI BioPharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

CTI BioPharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

CTIC Industry Peers

Company Price Change (%)
Arrowhead Pharma (ARWR)2.170.02 (0.91%)
Acelrx Pharma (ACRX)3.10 (0%)
Baxalta (BXLT)46.020.18 (0.39%)
Cerulean Pharma (CERU)1.410 (0%)
Ambit Biosciences (AMBI)15.60 (0%)
Teva Pharmaceutical (TEVA)35.20.61 (1.7%)
Incyte (INCY)120.490.31 (0.26%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Esperion Therapeutics (ESPR)251.81 (7.81%)
Cempra (CEMP)3.350.18 (5.67%)
Portola Pharma (PTLA)31.681.41 (4.66%)
Tesaro Inc (TSRO)190.367.8 (4.27%)
Genocea Biosciences (GNCA)4.60.16 (3.6%)
Achaogen (AKAO)22.680.68 (3.09%)
ChemoCentryx (CCXI)7.040.21 (3.07%)
Top gainers from Medical-Drugs industry
* As of Feb 18, 2017
CompanyPriceChange (%)
ArQule (ARQL)1.20.27 (18.37%)
Infinity Pharma (INFI)2.440.13 (5.06%)
ImmunoGen (IMGN)2.430.07 (2.8%)
Lannett Co (LCI)22.40.6 (2.61%)
Zogenix (ZGNX)10.20.25 (2.39%)
La Jolla Pharma (LJPC)18.970.46 (2.37%)
Depomed (DEPO)16.470.38 (2.26%)
Top losers from Medical-Drugs industry
* As of Feb 18, 2017

CTI BioPharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues16.11M60.07M34.67M--
Net Income-119.42M-93.36M-42.74M-101.37M-62.36M
Total Operating Expense130.83M145.41M76.06M101.48M62.73M
view CTI BioPharma Corp income statement
balance sheet20152014201320122011
Total Assets144.33M92.28M93.72M73.71M62.23M
Total Liabilities96.91M52.36M37.5M27.3M20.76M
Shareholders Equity47.41M39.92M56.21M46.4M41.47M
view CTI BioPharma Corp balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities7.45M9.68M-3.79M2.91M-3.85M
Net Cash From (Used By) Operating Activities-95.2M-39.55M-35.83M-62.77M-60.45M
Increase (Decrease) In Prop Plant And Equipment-0.07M-0.33M-1.53M-2.93M-2.67M
view CTI BioPharma Corp cashflow statement

CTI BioPharma Corp Stock News - Partner Headlines

CTI BioPharma Stock Message Board

CTI BioPharma stock price ended the last trading day at 4.73. The total market value as denoted by 133.8M for CTI BioPharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing CTI BioPharma stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy CTIC stock than sell it, then CTI BioPharma stock price goes up. Conversely, if more investors wanted to sell CTIC stock than buy it, there would be greater supply than demand, and the stock price would fall. 68066 shares were traded with a closing stock price of 4.73 as of 17 Feb, 2017, as can be seen from CTI BioPharma stock quote. One can view CTI BioPharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. CTI BioPharma does not pay dividends. CTI BioPharma stock price history, gives the entire historical data for CTIC stock.